Category: Friday Forensic
-
![Revive Therapeutics (RVV.C) finds multiple research options moving forward]()
Revive Therapeutics (RVV.C) finds multiple research options moving forward
In Canada, if you look backwards over the timeline, you’ll often find public companies have been other things back in the day. Risen, fallen, tapped out, rolled back, reemerged as a whole new thing. Sometimes this happens several times before a business model catches. Revive Therapeutics (RVV.C) is that rare Canadian smallcap that, while it…
-
![Perimeter Medical Imaging AI (PINK.V): After 3 years, it’s half-priced, AI-based, and in FDA trials]()
Perimeter Medical Imaging AI (PINK.V): After 3 years, it’s half-priced, AI-based, and in FDA trials
If you’ve been around here for a while, like going back three years or so ago, you may recall a former client company in Perimeter Medical Imaging (PINK.V). I really loved repping PINK, because sometimes it’s nice to be able to say that you really ARE trying to cure cancer, and make some profit while…
-
![Lucy Loves Luchre: Psyence Group (PSYG.C) was always just a shroom chaser]()
Lucy Loves Luchre: Psyence Group (PSYG.C) was always just a shroom chaser
The boss has told me to start running the rule over weed and psychedelics companies with a view to picking out anything that’s quietly profitable, or could be soon, among the general dross of both sectors, and to say I’m excited by that would be an overstatement. In general, cannabis companies are hamstrung by government…
-
![Lophos Holdings (MESC.C) is selling peyote soon, and you didn’t even know]()
Lophos Holdings (MESC.C) is selling peyote soon, and you didn’t even know
Lophos Holdings (MESC.C) is a Canadian public company – the only public company – specifically focused on the quickly liberalizing psychedelics sub-sector of Peyote and Mescaline. You may be sitting back in your chair now thinking, “Well hello there,” and I’m with you. For most of my life, peyote was a thing we did with…
-
![Lucy Loves Luchre: Medexus Pharmaceuticals (MDP.T) is growing fast, keeping the bottom line trim]()
Lucy Loves Luchre: Medexus Pharmaceuticals (MDP.T) is growing fast, keeping the bottom line trim
Hey y’all, Lucy Copperpot back for more analysis of Equity.Guru companies – this one is no longer on the client list, but I asked for permission to dig in anyway because I really think a ton of risk has been removed from Medexus Pharmaceuticals (MDP.T) that the market hasn’t factored in, and that’s a real…
-
![Roof blows off Benton Resources (BEX.V) stock as Falcon Gold (FG.V) lifting hard nearby]()
Roof blows off Benton Resources (BEX.V) stock as Falcon Gold (FG.V) lifting hard nearby
Over the last few days, holders of Benton Resources (BEX.V) stock have been eating steak and getting measured for yacht wear. Bastards. If you want to know why, it’s because of the following, on a project Benton has optioned from Spruce Ridge Resources (SHL.C) : BENTON HITS MULTIPLE HIGH GRADE COPPER ZONES IN FIRST TWO…
-
![Ashley Gold (ASHL.C) storms up 41.2% as CEO literally lifts rocks]()
Ashley Gold (ASHL.C) storms up 41.2% as CEO literally lifts rocks
When people saw Ashley Gold (ASHL.C) was a $0.065 stock a few days ago, they may have ignored it as just another little gold explorer at a time when gold explorers are largely unloved. We wrote about it because we liked the guys behind it, and their plans to work it when everyone else in…
-
![Friday Forensic: Is the run on Emerita Resources (EMO.V) sustainable?]()
Friday Forensic: Is the run on Emerita Resources (EMO.V) sustainable?
Okay, everybody shush now and pay attention, because the markets are crap and your portfolio has been hurting and we’re just bloody sick of all that. It’s time to make some money on a runner and your old pal spotted one a month ago that has been buying daddy a lot of steak.. Emerita Resources…
-
![Emerita Resources (EMO.V) begins to climb as the dust settles on big financing]()
Emerita Resources (EMO.V) begins to climb as the dust settles on big financing
If there are two things that are predictable in mining exploration, it’s that a rollback will bring a short term stock price drop (it shouldn’t, but it does), and that an under-priced financing will see the stock price fall to the financing price. The reason for that second one is simple.. if the stock is…
-
![How to research stocks if you’re not an analyst but still want to go deep]()
How to research stocks if you’re not an analyst but still want to go deep
The land beyond price targets Price targets are an animal I’ve never really taken seriously. This artificially created number gets taken as a realistic goal for many investors, which I guess has value, but price targets are often backed in more ways than one from the funds/investment banks like Cannacord or Eight Capital who put…
